Skip to content

Brown adipose tissue after vagus nerve stimulation

Brown adipose tissue after vagus nerve stimulation - Brown adipose tissue after vagus nerve stimulation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON38162
Enrollment
20
Registered
2011-02-04
Start date
2011-04-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brown fat obesity

Interventions

In this study the VNS-system is switched off temporarily. This is not part of the regular VNS treatment. Theoretically this could influence the frequency of epileptic insults. On the other hand VNS

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Subjects treated with Vagus Nerve Stimulation (VNS) for epilepsy, aged 18-65 years, with a Body Mass Index (BMI)

Exclusion criteria

Exclusion criteria: • Body Mass Index > 28 kg/m2 • Daily epileptic insults. • Subjects that need or needed *Rapid Cycling* VNS to control their frequency of epileptic insults. • Psychological unstable subjects (as judged by the treating neurologist). • subjects with mental retardation (as judged by the treating neurologist). • subjects with severe behaviour disorders (as judged by the treating neurologist). • Pregnant subjects. • Subjects that previously underwent high dose radiation for diagnostic or therapeutic purposes (radiotherapy, high frequency CT-scans). • The use of the following medication is an exclusion criterium; o ß-blockers, o Ketogenic diet • Subjects that recieved high doses of ionising radiation (x-ray or gamma radiation) in their medical history will be excluded.

Design outcomes

Primary

MeasureTime frame
The main endpoint of this study is BAT activity in kBq after active VNS.

Secondary

MeasureTime frame
Secondary endpoints are the effect of VNS on energy expenditure, body core temperature, skin surface temperature, skin perfusion and food intake. Other study parameters Other relevant study parameters are medical history, medication, current medical status, age, body weight, weight history, height, sex, thyroid gland function, and UCP-1 and beta3-receptor polymorphisms.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)